Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 214053
Company: APOTEX

Products on ANDA 214053

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE	EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	120MG;EQ 15MG BASE	TABLET;ORAL	Prescription	AB	No	No
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE	EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	200MG;EQ 25MG BASE	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 214053

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/17/2024	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 214053

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

TABLET;ORAL; 120MG;EQ 15MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DESCOVY	EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	120MG;EQ 15MG BASE	TABLET;ORAL	Prescription	Yes	AB	208215	GILEAD SCIENCES INC
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE	EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	120MG;EQ 15MG BASE	TABLET;ORAL	Prescription	No	AB	214053	APOTEX

TABLET;ORAL; 200MG;EQ 25MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DESCOVY	EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	200MG;EQ 25MG BASE	TABLET;ORAL	Prescription	Yes	AB	208215	GILEAD SCIENCES INC
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE	EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	200MG;EQ 25MG BASE	TABLET;ORAL	Prescription	No	AB	214053	APOTEX